The Pennine Acute Hospitals
NHS Trust Formulary
 
back
11 Eye
11-08-02 Subfoveal choroidal neovascularisation

Ranibizumab Lucentis®
First Choice
Intravitreal injection

Restricted Item Ophthalmic consultant only

Use as per GMMMG Macular Drugs Pathway
Link  GMMMG: Macular Drugs Pathway
Link  NICE TA155: Ranibizumab for the treatment of age-related macular degeneration
Link  NICE TA274: Ranibizumab for treating diabetic macular oedema
Link  NICE TA283: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
Link  NICE TA298: Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Aflibercept Eylea®
First Choice
Intravitreal injection

Restricted Item Ophthalmic consultant only

Use as per GMMMMG Macular Drugs Pathway
Link  GMMMG: Macular Drugs Pathway
Link  NICE TA294: Aflibercept for treating wet age-related macular degeneration
Link  NICE TA346: Aflibercept for treating diabetic macular oedema
Link  NICE TA486: Aflibercept for treating choroidal neovascularisation
Link  NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
Link  NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Bevacizumab intravitreal injection
Formulary
Ocular injection

Restricted Item Named-patient use only. For existing patients only. Ophthalmic consultant only

unlicensedunlicensed

Red View adult BNF  View SPC online  View childrens BNF
Pegaptanib Sodium Macugen®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Verteporfin Visudyne®
Non Formulary

View adult BNF  View SPC online  View childrens BNF